IQM Quantum Computers

1.1 Identity, Product Scope, and Operating Model

IQM Quantum Computers presents itself as a full-stack superconducting quantum computing company rather than a component supplier or pure cloud API layer. The official about, products, and investor materials converge on the same core identity: IQM builds on-premise quantum computers, offers cloud access, and emphasizes that customers should be able to own and operate their systems directly. That matters because the company is not only selling qubits; it is selling an operating model built around sovereignty, local ecosystem development, and integration with high-performance computing environments. The current product family spans entry-level education hardware, higher-end research and HPC systems, a fault-tolerance-oriented Halocene line, and the Resonance cloud environment. This breadth suggests IQM is trying to cover the full maturation path from workforce development and experimentation to institutional production deployments, which makes the company overview materially different from a single-product startup story.[CO001, CO002, CO003, CO004, CO005, CO006]

1.2 Leadership, Governance, and Organizational Maturity

Leadership evidence is strongest on the founder-operator layer and thinner on the full board and control stack. Public company releases show Jan Goetz moved from a co-CEO structure to sole CEO in January 2026, with Søren Hein appointed chief operating officer and deputy CEO and former co-CEO Mikko Välimäki transitioning to an advisory role through March 2026. The same releases and public-market materials also show that Sierk Poetting served as board chair and that Alex Doll of Ten Eleven Ventures joined the board after the 2025 Series B. Together these facts indicate a company moving from founder-led buildout toward a more formal scale-up governance model. But the public evidence still does not provide a complete current board roster, committee structure, or investor-rights map. For diligence purposes, IQM looks mature enough to support large institutional deployments and a listing process, yet still private enough that real governance power remains partially opaque outside core press releases and transaction documents.[CO014, CO015, CO016, CO017, CO022, CO036]

1.3 Funding History, Capitalization, and Investor Base

IQM’s financing trajectory is now central to its identity. Historical materials show the company moving from seed funding and a €39 million Series A1 to a €128 million A2-era raise, then to a 2025 Series B worth $320 million (€275 million) that brought total capital raised above $600 million. By 2026, the company layered a €50 million BlackRock-managed financing package on top of that history and announced a public-market transaction valuing the business at roughly $1.8 billion pre-money. The investor mix is notable because it blends traditional venture capital, sovereign and pension capital, corporate strategic money, and public-market PIPE capital. That gives IQM more financing diversity than a typical deep-tech hardware startup, but it also raises the burden of proof on execution: once 2025 revenue, bookings, and expected post-close cash are disclosed, underwriting shifts from technical promise alone toward commercialization credibility. The biggest remaining blind spots are ownership concentration, liquidation preferences, and whether any secondary liquidity occurred before the public-market process.[CO010, CO011, CO012, CO013, CO014, CO018]

1.4 Commercial Scale, Geographic Footprint, and Deployment Proof

The most important update versus IQM’s earlier financing-era profile is the amount of deployment evidence now in public view. March and April 2026 releases showed a fourth deployed system in Finland at Aalto University, Japan’s first enterprise quantum computer purchase via TOYO, and the first private-enterprise purchase through Poland’s Galaxy Systemy Informatyczne. Additional 2025-2026 releases document deployments or integration work with Oak Ridge National Laboratory, EuroHPC-linked LUMI-Q infrastructure, and channel expansion in Taiwan. These announcements do not prove recurring software economics, but they do show that IQM is no longer selling only a future roadmap. The footprint also now extends beyond the earlier Europe-centric narrative: Oulu strengthens Finland R&D, Maryland anchors the U.S. ecosystem strategy, and APAC channel and enterprise activity support the claim that IQM is trying to win local infrastructure positions rather than remain a single-site lab supplier. The open question is not whether deployments exist, but how repeatable and economically durable they are.[CO022, CO023, CO024, CO025, CO026, CO027]

1.5 Milestones, Risk Signals, and Remaining Diligence Gaps

IQM’s milestone record is unusually dense for a still-private quantum hardware company: foundation in 2018, early institutional deployments, a record European Series B in 2025, facility expansion, leadership restructuring, a SPAC route to public markets, and customer milestones across Finland, Poland, Japan, Germany, and the Czech Republic. That sequence supports a thesis of a company moving from ecosystem building to commercial infrastructure. At the same time, the company’s own legal and financing disclosures warn that quantum computing remains an emerging technology with significant technical challenges, limited operating history, historical losses, dependence on continued financing, and exposure to government or state-funded customers. Those are not edge-case caveats; they go directly to how IQM should be underwritten. The public materials are strong enough to establish identity, capital access, and real deployments, but not yet strong enough to answer cap-table control, customer concentration, or recurring-revenue quality with precision.[CO011, CO015, CO018, CO023, CO024, CO025]

2.1 Market Boundary and Scope

The right market frame for IQM is narrower than “all quantum technology” and more specific than a generic quantum-computing TAM. IQM’s public materials point to superconducting quantum systems, cloud access, control electronics, integration software, and HPC-operating workflows as the relevant commercial surface. That means the company sits in the quantum-computing market, but not in all quantum spending: sensing, networking, and post-quantum cybersecurity matter strategically yet are not the same budget pool as full-stack superconducting computing systems. The deployment model also matters. Public market reports disagree on whether cloud or on-premises is the more important near-term commercial form, but they agree that both exist and that deployment choice changes adoption barriers. IQM’s own positioning leans hard toward owned, on-premise infrastructure with cloud as an access layer, which makes its true addressable market more akin to quantum infrastructure plus integration than a broad “software only” category.[CM001, CM002, CM003, CM004, CM005, CM020]

2.2 Sizing Lenses and Estimate Dispersion

Accessible market estimates broadly agree on growth but not on the exact size of the opportunity. Precedence Research puts the market at $1.44 billion in 2025 and $19.44 billion by 2035, Grand View estimates $1.42 billion in 2024 and $4.24 billion by 2030, MarketsandMarkets sees $3.52 billion in 2025 rising to $20.20 billion by 2030, QED-C says the overall 2025 quantum market is $1.9 billion with computing above $1.4 billion and heading beyond $3 billion by 2028, and IQM/Omdia argues for more than $22 billion by 2032. Those are not small differences. They imply that the category boundary is unstable, that some reports include broader services or adjacent quantum layers, and that any single TAM headline is too fragile to anchor underwriting alone. The market is certainly meaningful, but the better diligence habit is to use multiple lenses and translate them into concrete buyer pathways, deployment models, and use-case readiness rather than rely on one optimistic forecast chart.[CM006, CM007, CM008, CM009, CM010, CM011]

2.3 Buyer Segments, Deployment Models, and Adoption Path

The buyer map is broader than one vertical and narrower than “all enterprises.” Across market reports and IQM’s own deployment evidence, the strongest current buyer groups are supercomputing centers, universities, national laboratories, public-sector ecosystem programs, and a still-small but visible enterprise cohort. Reports consistently point to BFSI, drug discovery, materials science, optimization, and machine learning as attractive application areas, but those use cases do not all translate into the same procurement route. In practice, cloud access lowers the barrier to experimentation, while on-premise ownership matters for sovereign control, IP retention, security, and tight HPC integration once institutions move beyond basic experimentation. IQM’s AWS Braket presence shows it cannot ignore cloud channels, yet its most differentiated commercial thesis remains the idea that customers eventually want to own systems and operate them inside classical infrastructure. The adoption path therefore runs from exploration, to hybrid integration, to owned production environments, not from pure SaaS trial straight to mass enterprise rollout.[CM004, CM012, CM013, CM014, CM020, CM021]

2.4 Growth Drivers, Constraints, and Open Questions

The strongest growth drivers are easy to identify: rising demand for higher-performance computation, heavy government funding, public-private infrastructure programs, cloud-based access that broadens experimentation, and a growing belief that optimization, simulation, and selected chemistry or drug workloads may be valuable earlier than generalized fault tolerance. But the same sources also make clear why commercialization remains hard. Talent is scarce, the supply chain is specialized, cryogenic and control infrastructure are expensive, qubit error rates still matter, integration into classical systems is non-trivial, and export-control or national-security concerns can shape how systems move across borders. Even bullish industry groups continue to say useful applications are a few years away rather than fully present now. For IQM, that means the market thesis is neither “hype only” nor “already mature.” It is a real but bottlenecked infrastructure market where execution quality, ecosystem building, and operational simplicity determine whether large forecasts convert into actual installed-base economics.[CM015, CM016, CM017, CM018, CM019, CM025]

3.1 Landscape: gate-model giants, trapped-ion challengers, cloud-only players, and annealing alternatives

IQM competes across several distinct competitor classes, each pursuing quantum advantage through different technical strategies and market postures. The landscape as of May 2026 can be divided into four categories. First, **hyperscaler-backed gate-model incumbents**: IBM Quantum operates more than 2,300 available qubits across 30+ quantum computers with over 100 qubits each, runs 3.9 trillion circuits per year, and claims 97% uptime. IBM's scale and vertical integration through IBM Quantum System Two positions it as the default reference platform for large HPC centres worldwide. Google Quantum AI introduced its Willow chip in 2024–2025, achieving the first verifiable quantum advantage toward real-world applications via the Quantum Echoes algorithm, and continues to operate as an internal research-and-partnerships organisation rather than a commercial hardware vendor. Second, **trapped-ion specialists**: IonQ and Quantinuum compete primarily on fidelity. IonQ claims a 99.99% two-qubit gate fidelity benchmark — the highest publicly published in the industry — and is distributing access through AWS, Azure, and Google Cloud. Quantinuum's Helios processor uses a QCCD (quantum charge-coupled device) architecture with all-to-all connectivity and mid-circuit measurement capability, enabling the first-ever real-time quantum error correction demonstrations. Third, **cloud-only superconducting peers**: Rigetti Computing deployed its Cepheus-1-108Q (107 physical qubits) in April 2026, with 99.84% median single-qubit gate fidelity and 98.84% CZ gate fidelity. Rigetti operates cloud-only through its Quantum Cloud Services (QCS) and does not sell on-premises systems, which creates a direct positioning gap versus IQM. Fourth, **quantum annealing alternatives and diversified players**: D-Wave offers a dual-platform approach combining its established Advantage2 annealing system with gate-model capability gained through the acquisition of Quantum Circuits Inc. D-Wave is the only commercially profitable quantum vendor on a service basis, though its annealing technology addresses a narrower problem class than gate-model computers. IQM's unique position is on-premises superconducting hardware for national HPC centres, research labs, and government institutions. The company claims to be the number-one provider of on-premises quantum computers by delivery count over the last twelve months, with 15+ customer deliveries and 30+ machines manufactured total. The AWS Braket integration (IQM Garnet 20-qubit and Emerald 54-qubit) provides a cloud presence, but the on-premises segment is IQM's primary commercial differentiator versus cloud-dominant rivals.[CP001, CP002, CP003, CP004, CP005, CP006]

3.2 Profiles: scale, strategy, target segment, and pricing posture by competitor

**IBM Quantum** is the largest and most widely deployed quantum computing platform globally. IBM's quantum computers are accessible through the IBM Cloud and through direct on-premises installations in academic and research settings. IBM Quantum System Two is its modular, data-center-grade architecture combining multiple QPUs with classical compute. IBM uses 300mm semiconductor fabrication to manufacture superconducting transmon qubits and has cut processor build times by at least half through semi-automated tooling. IBM does not publish unit pricing for on-premises systems; cloud access is priced by circuit execution time. IBM's primary target is large enterprise and national-lab customers seeking validated integration with classical HPC infrastructure. IBM's strategic direction is toward quantum-centric supercomputing through modular interconnect (l-couplers) and the development of cryogenic CMOS control electronics to reduce complexity. **Google Quantum AI** operates as a research organisation rather than a commercial hardware vendor. It does not sell quantum computers to external customers; instead it collaborates with select partners and offers access to Willow via Google Cloud (via a private beta/partnership model). Google's competitive threat to IQM is primarily at the frontier-research level, where Google's verifiable quantum advantage claims raise the bar for what national research programmes need to acquire. **IonQ** is a publicly traded company (IONQ on NYSE) that sells cloud-based access to its trapped-ion systems through AWS, Azure, and Google Cloud. IonQ is expanding beyond quantum computing into quantum networking, quantum security (QKD), quantum sensing, and space infrastructure. IonQ's trapped-ion approach offers higher two-qubit fidelity (99.99% claimed) versus IQM's superconducting Radiance (99.5% typical), but gates are slower and scale-up to thousands of physical qubits is technically harder. IonQ's roadmap calls for 2 million physical qubits eventually, but the path from trapped-ion demonstration devices to that scale is unproven. **Quantinuum** (Honeywell Quantum Solutions + Cambridge Quantum) operates Helios and its H-series trapped-ion processors. The QCCD architecture enables all-to-all connectivity, drastically reducing SWAP overhead versus superconducting square-lattice designs. Quantinuum distributes through Microsoft Azure and through direct subscriptions. Quantinuum's strategic focus is on fault-tolerant quantum computing for chemistry, materials simulation, and cybersecurity. Quantinuum's fidelity claims are the strongest in the trapped-ion space and compete directly with IonQ; its Microsoft Azure go-to-market gives it superior enterprise distribution versus IQM. **Rigetti Computing** (RGTI on NASDAQ) is IQM's most direct modality peer — both use superconducting transmon qubits with tunable couplers. Rigetti's Cepheus-1-108Q (107 qubits, deployed April 2026) slightly exceeds IQM Radiance's current standard 20-qubit configuration in qubit count but is available cloud-only. Rigetti's FY2024 10-K filings reveal persistent losses ($201M net loss FY2024, $75.1M in FY2023) and heavy reliance on US government contracts (89.4% of revenue in FY2024). This makes Rigetti a warning model for IQM's own financials: without on-premises hardware revenue, cloud-only quantum services remain pre-commercial. **D-Wave** focuses on quantum annealing for combinatorial optimisation, a problem class with industrial applications in logistics, scheduling, and finance. D-Wave's acquisition of Quantum Circuits Inc. brings gate-model capability, but its primary competitive threat to IQM is in the optimisation segment where NISQ superconducting computers also seek applications. D-Wave explicitly benchmarks rival quantum vendors using three criteria and frames much of its marketing around "deflating the hype," implicitly arguing that NISQ gate-model vendors, including IQM-class companies, have not yet demonstrated sufficient commercial value.[CP001, CP002, CP003, CP004, CP005, CP007]

3.3 Capability, pricing, and GTM comparison: on-premises vs cloud-first, fidelity benchmarks, and distribution reach

The key buying criteria for an institutional quantum computing customer — national lab, HPC centre, university, or deep-tech enterprise — include qubit count, gate fidelity, hardware control access (pulse-level vs gate-level), deployment model (on-premises vs cloud), geographic data sovereignty, integration with classical HPC, and total cost of ownership. **Qubit count and fidelity**: IBM leads on raw qubit count (2,300+ available), but IQM's Emerald 54-qubit chip achieves 99.93% median single-qubit fidelity and 99.5% median CZ fidelity — competitive with the best superconducting systems. IQM Spark achieves ≥99.9% single-qubit fidelity typical for its 5-qubit university system. Rigetti's Cepheus-1-108Q posts 99.84% single-qubit and 98.84% CZ fidelity. Trapped-ion systems (IonQ, Quantinuum) achieve higher per-gate fidelity (99.99% for IonQ) but operate at lower qubit counts and slower gate speeds. **Hardware access**: IQM provides full pulse-level access to its hardware — a feature that IBM cloud does not offer by default — which is critical for research labs that need to customise qubit control, benchmark error channels, and develop hardware-specific algorithms. This is a genuine differentiator for the European and Asian research-lab segment. **Deployment model**: IQM is the only major vendor with a dedicated on-premises product line spanning 5 qubits (Spark), 20/54 qubits (Radiance), and a 24-qubit star-topology device (Star 24), alongside a cloud service (IQM Resonance). IBM also sells on-premises (IBM Quantum System Two), but primarily targets HPC and data-centre scale deployments. Rigetti, IonQ, and Quantinuum are cloud-first (or Microsoft-Azure-first in Quantinuum's case). D-Wave offers Advantage2 both on-premises and via cloud. **Pricing**: IQM Resonance cloud pricing ranges from free (30 credits/month, Starter tier) to $0.30/second for pay-as-you-go QPU access. On-premises hardware pricing is not publicly listed; estimated contract values for HPC-integrated systems are in the multi-million euro range based on government contract disclosures. IBM, Quantinuum, and IonQ all use custom enterprise pricing with no public list price for on-premises or large-volume cloud. **GTM and distribution**: IBM and Google distribute through existing cloud and enterprise sales channels with deep incumbent relationships. IonQ and Quantinuum have expanded through major cloud marketplace integrations (AWS, Azure, Google Cloud) that IQM does not yet fully match. IQM's AWS Braket integration with Garnet and Emerald is a start, but IQM's core go-to-market relies on direct institutional sales, government partnerships, and national quantum programmes in Europe (Finland, Germany), APAC (Japan, South Korea), and the US.[CP002, CP006, CP007, CP015, CP016, CP021]

3.4 Moat durability, switching costs, and displacement risk

IQM's most defensible competitive position is the combination of (1) in-house European chip fabrication (Espoo, Finland), (2) sovereign on-premises delivery to national quantum programmes, and (3) growing institutional relationships cemented by multi-year maintenance and cloud-platform contracts. The VTT contract (150-qubit system mid-2026, 300-qubit late-2027) is the most visible anchor of this strategy: once VTT operates IQM hardware and trains its researchers on IQM's software stack, migration to a competing platform has substantial cost and transition risk. However, several displacement risks are real. IBM's scale and global distribution give it the ability to respond to European national quantum programmes with attractive pricing or partnership deals; the US National Quantum Initiative and EU Quantum Flagship initiatives both involve IBM. Google's Willow chip demonstrated exponential error reduction with qubit count, which — if scalable — could eventually leapfrog superconducting NISQ platforms entirely. IonQ and Quantinuum's trapped-ion approach, if it achieves fault-tolerant error correction earlier than superconducting systems, could shift the preferred platform for fault-tolerant workloads. Switching costs for IQM's on-premises customers are high in the medium term. A university or national lab that purchases, installs, and trains on an IQM system has invested in calibration routines, custom pulse-level code, integration with local HPC infrastructure, and staff expertise. Migrating to a different hardware platform requires re-engineering algorithms, retraining operators, and likely replacing cryogenic infrastructure — a significant multi-year commitment. Cloud switching costs are lower: IQM Resonance competes on the same commodity layer as IonQ Cloud and IBM Quantum Cloud, where multi-homing is straightforward through framework adapters (Qiskit, PennyLane, CUDA-Q). The multi-homing risk is mitigated in on-premises but acute in cloud. IQM's ability to grow the cloud business (IQM Resonance) is limited by its current integration in only the AWS Braket ecosystem; it lacks direct Azure and Google Cloud Marketplace presence that IonQ and Quantinuum have already secured. This channel gap is a material risk if enterprise buyers adopt cloud quantum as the default and bypass the on-premises segment. IQM's 300+ patent applications represent a technical moat, but the quantum computing patent landscape is crowded with IBM, Google, and academic institution filings, and cross-licensing or design-around risk is non-trivial. The most durable competitive advantage may be operational — the ability to deliver and maintain 30+ working systems across multiple continents faster than any rival — rather than technology IP.[CP010, CP012, CP027, CP028, CP029, CP030]

3.5 Exhibits

4.1 Revenue Architecture and Monetisation Model

IQM generates revenue across four distinct streams. First, on-premises hardware sales represent the company's highest-value channel: institutional buyers (national laboratories, HPC centres, universities) purchase complete quantum computing stacks — dilution refrigerator, QPU, control electronics, and software — delivered and commissioned on-site. Contract sizes are not publicly disclosed, but the €70M multi-year VTT programme provides a datapoint: the Finnish government-funded contract to supply a 150-qubit system by mid-2026 and a 300-qubit system by late-2027 implies an average annual contract value in the range of €10–20M per year over the project lifetime. Second, IQM Resonance provides a self-service cloud platform with a free Starter tier (up to 30 credits per month) and a pay-as-you-go tier at $0.30 per second of QPU access time. Third, IQM's QPUs (Garnet 20-qubit and Emerald 54-qubit) are available on AWS Braket at $0.30 per circuit task plus a per-shot fee, reaching enterprise and academic users without direct IQM sales engagement. Fourth, milestone-gated government grants — including a €20.7M Finnish state grant (2020) and the EIB venture-debt loan of €35M (2022) for fabrication infrastructure — provide non-revenue capital that supports R&D and manufacturing. Revenue recognition for hardware contracts likely follows percentage-of- completion or milestone acceptance criteria, creating potential lumpiness in reported revenue upon IPO. IQM has not disclosed any revenue, ARR, gross margin, or EBITDA figures as of the run date; all income metrics are private-company confidential.

4.2 Go-to-Market Motion and Channel Economics

IQM's primary go-to-market is direct sales to government quantum programmes and institutional buyers. The company has offices in over 13 countries and claims more than 15 on-premises customer deliveries, making it the self-described #1 on-premises quantum computer vendor by delivery count over the last 12 months. The sales cycle for on-premises quantum hardware is long — typically 12 to 24 months — involving site qualification, government procurement processes, proof-of-concept trials, and contractual delivery milestones. Customer acquisition cost for such contracts is high, though not publicly quantified. IQM's cloud channel (AWS Braket) enables self-serve discovery and low-friction access, but generates lower revenue per customer than hardware contracts; it also serves as a developer and proof-of-concept funnel toward future on-premises upsell. The company lacks a Microsoft Azure Quantum or Google Cloud Marketplace listing as of the run date, limiting enterprise reach through Microsoft and Google partner networks — a gap exploited by competitors IonQ and Quantinuum, both of which maintain three-platform cloud presence. IQM's geographic expansion has prioritised European sovereign quantum programs (Germany, Finland, Spain, France), Asia-Pacific (Japan, South Korea), and the US via the Nasdaq IPO announcement. Distribution through systems integrators or quantum application service providers is not publicly confirmed; IQM appears to use direct-sales-only go-to-market for on-premises contracts.

4.3 Cost Structure, Capital Intensity, and Gross Margin Drivers

IQM's vertically integrated model — in-house chip fabrication, cryogenic system integration, control software, and field commissioning — generates higher cost-of-goods than fabless peers such as IonQ. The €35M EIB loan (2022) funded IQM's Espoo fabrication facility, the first quantum-dedicated clean-room fab in Europe. Owning fabrication provides supply-chain sovereignty and avoids dependence on external semiconductor foundries but requires continuous capex for equipment refresh, process development, and capacity expansion. Public comparable data from IonQ (which relies on external foundries) and Rigetti (which owns its Fab-1 facility in Fremont, California) suggest gross margins in quantum hardware are thin to negative at this stage: Rigetti reported $10.8M FY2024 revenue against $69M operating losses; IonQ reported $130M FY2025 revenue against $510M net losses. Neither publishes hardware-specific gross margin, as most revenue is embedded in multi-element contracts. IQM's headcount of 300+ employees across 13+ countries implies significant fixed personnel cost. At a quantum-sector blended loaded annual cost of approximately $150K–$250K per employee (salary plus employer contributions), the payroll alone implies a $45–75M annual personnel cost before R&D materials, fab operating costs, and SG&A. This is consistent with an estimated total annual burn in the $60–100M range, though no data has been confirmed publicly.

4.4 Financial Metric Gaps and Transparency Assessment

IQM is pre-IPO and subject to no public disclosure requirements as of the run date. A search of the SEC's EDGAR database confirms that no S-1, F-1, or registration statement has been filed under "IQM" as of May 26, 2026 — the IPO announcement was made on February 23, 2026, but the prospectus filing had not yet been submitted. Key financial metrics that remain undisclosed include: annual revenue, ARR, recognised contract backlog, gross margin, EBITDA, operating cash flow, cash and equivalents, total debt, and customer concentration metrics. The only confirmed capital events are the individual funding rounds (Seed through Series B) and the EIB loan, plus the VTT contract which provides a partial revenue anchor. Material diligence blockers include the absence of (1) multi-year revenue trend, (2) hardware gross margin to assess pricing power, (3) burn rate and cash runway post-Series B, and (4) customer contract concentration data. The analogous peer trajectory (IonQ: IPO at $2B SPAC valuation Oct 2021, revenue $130M by FY2025 but still loss-making; Rigetti: IPO at $1.5B SPAC valuation Mar 2022, revenue $10.8M in FY2024, still loss-making) suggests that post-IPO, IQM will be required to publish quarterly earnings but that near-term profitability is unlikely. Investors proceeding ahead of the prospectus are effectively underwriting pre-commercial quantum hardware risk with limited financial visibility.

4.5 Capital Adequacy, Financing History, and IPO Context

IQM has raised over €600M in aggregate financing since its 2018 founding, placing it among the best-capitalised private quantum hardware companies globally. The September 2025 Series B of €275M ($320M), led by Ten Eleven Ventures — IQM's first US institutional investor — marked the largest quantum funding round in European history and the fourth largest funding round for a Finnish growth company to date. Co-investors included Elo Mutual Pension Insurance, Varma Mutual Pension Insurance, Companies of Schwarz Group, Winbond Electronics, European Innovation Council (EIC), and Bayern Kapital. On February 23, 2026, IQM announced plans to list on the Nasdaq at an initial valuation of approximately $1.8B. No S-1 or F-1 has been filed as of the run date. Post-Series B capital position appears strong: at an estimated $60–100M annual burn, the €275M Series B alone provides approximately 2.5–4 years of runway, suggesting IQM can execute the IPO without a distressed financing need in the near term. Planned use of proceeds likely includes: completion of the VTT 300-qubit delivery (late 2027), manufacturing scale-up for additional commercial on-premises orders, Resonance platform development, error-correction R&D, and US market entry. The $1.8B initial valuation is a 3× premium to Rigetti's SPAC valuation ($1.5B in 2022) but modest relative to IonQ's current $6.57B total assets. The US CHIPS and Science Act's $2.013B in quantum letters of intent (signed May 2026 by the US Department of Commerce) signals robust US government demand for domestic and allied quantum capabilities — a backdrop that could support IQM's US commercial expansion post-listing.

4.6 Exhibits

5.1 Product Portfolio and SKU Map

IQM's commercial product lineup spans four distinct product lines that address different market segments from education to HPC-scale research. IQM Spark is a 5-qubit on-premises system priced for universities and research centers; it uses the IQM Crystal topology with tunable couplers and was chosen for Cineca's Lagrange installation in Italy and Chungbuk National University in South Korea. IQM Radiance targets high-performance computing centers with configurations at 20, 54, and 150 qubits (Crystal 20, Crystal 54, Crystal 150), all featuring full square-lattice connectivity, tunable couplers between all nearest-neighbor qubit pairs, and a software stack for HPC integration. Radiance 20 is deployed at LRZ (Leibniz Supercomputing Center), ORNL, and Aalto University; Radiance 54 is planned for CESGA; Crystal 150 is the flagship for VTT. IQM Halocene is the newest product line, announced November 2025, targeting the quantum error correction research era with a modular open-platform architecture supporting up to 5 high-quality logical qubits, a modular decoder architecture, and NVIDIA NVQLink compatibility, with commercial availability targeted by end of 2026. IQM Resonance is the company's cloud platform at resonance.iqm.tech, providing access to IQM Star 24 (24-qubit, high-connectivity Star topology) and Crystal 54 hardware, with Qrisp as the default SDK, alongside support for Qiskit, Cirq, and CUDA Quantum. Additionally, IQM hardware is available via Amazon Braket (IQM Garnet: 20-qubit Crystal and IQM Emerald: 54-qubit Crystal 54). The company states it manufactures 20 on-premises quantum computers annually from its Espoo, Finland, facility. [CE001, CE002, CE003, CE004, CE005, CE006]

5.2 Hardware Architecture and QPU Design

IQM's quantum processing units are based on superconducting transmon qubits—a well-established qubit technology derived from Josephson junction circuits that provides high reproducibility and compatibility with standard microwave control electronics. Two proprietary topologies differentiate IQM's hardware. The IQM Crystal topology arranges qubits in a 2D square lattice with tunable couplers between each nearest-neighbor pair; this enables fast (20–40 ns) parallel two-qubit gates and minimizes crosstalk by fully idling coupler interactions during non-gate intervals. The IQM Star topology introduces a central computational resonator hub that connects a large number of qubits, providing effective near-all-to-all connectivity while reducing the number of SWAP operations required for connectivity-intensive algorithms; the IQM Star 24 (24-qubit) is the first commercial Star system and is accessible through the Resonance cloud platform. A third topology, IQM Constellation—combining Crystal and Star elements—is planned as the scalable architecture for quantum error correction, forming the basis for the QLDPC roadmap. The hardware stack comprises the QPU, a dilution refrigerator maintaining temperatures near 15 mK, wiring and filtering subsystems, and proprietary control electronics that send microwave, RF, and DC signals. Key performance benchmarks for the Crystal 20 production system include: minimum 1-qubit gate fidelity ≥99.7%, typical ≥99.9%; minimum 2-qubit CZ gate fidelity ≥98.0%, typical ≥99.0%; readout fidelity ≥97% typical; quantum volume 32; CLOPS 2600; Q-score 11. In 2025 IQM achieved 99.95% peak CZ fidelity on a two-qubit test chip. The company fabricates QPUs in an in-house clean room at its Espoo facility, using cryogenic chip testing to identify functional units before production. [CE010, CE011, CE012, CE013, CE014, CE015]

5.3 Software Stack, Cloud Platform, and HPC Integration

IQM's full-stack software offering encompasses quantum programming frameworks, compilation tools, automated calibration, and HPC integration middleware. The IQM SDK (open-source, Apache 2.0 license, on PyPI as iqm-client and in the GitHub repository iqm-finland/sdk) provides the client-side interface for IQM quantum computers. The default frontend framework on IQM Resonance is Qrisp, an open-source high-level quantum programming language, while Qiskit, Cirq, CUDA Quantum, and TKET are also supported. Quantum compilers translate high-level circuits to native IQM gates (X/Y rotations and CZ); automated calibration software maintains optimal parameter values. Pulse-level access is available to both on-premises customers and Resonance cloud users, enabling research-grade experimental control. The IQM Resonance platform at resonance.iqm.tech offers multi-framework support, group and user management, job scheduling, and transparent execution without hidden circuit modifications. A QAOA open-source library was released by IQM for quantum optimization algorithm research. For HPC integration, IQM delivers a specialized SDK enabling scheduling of quantum jobs directly from supercomputer job schedulers (as demonstrated at LRZ with the Munich Quantum Software Stack). IQM distinguishes "loose HPC integration" (quantum and classical scheduled independently but co-located, as at LRZ) from planned "tight HPC integration" (optimized data movement and latency). An HPC Integration Guidebook was published to assist HPC centers. In May 2026, IQM launched an HPC Integration Service product. On April 14, 2026, IQM announced AI-driven agentic calibration using NVIDIA Ising models, enabling parallel qubit calibration to reduce dependence on on-site quantum engineering expertise. IQM also collaborates with Zurich Instruments and NVIDIA on NVQLink for real-time QEC GPU-QPU interconnect (announced March 2026). [CE019, CE020, CE021, CE022, CE023, CE024]

5.4 Technology Roadmap and Development Milestones

IQM's published development roadmap defines three phases on the path to fault-tolerant quantum computing. Phase 1 (NISQ, 2025–2026): target >99.94% two-qubit gate fidelities in large systems; deploy advanced error suppression and mitigation techniques; deliver NISQ solutions for simulation and optimization use cases with research partners. Phase 2 (QEC Demonstrators, 2027–2028): build large systems combining QEC and error reduction; target logical error rates in the range 10⁻⁵ to 10⁻⁶; implement QLDPC codes offering 2–10× efficiency over surface codes; support universal quantum computation including non-Clifford gates. Phase 3 (Fault Tolerance, 2030+): realize fully QEC-enabled systems with hundreds of high-precision logical qubits; target logical error rate 10⁻⁹; scale to 1 million physical qubits. Specific technology milestones include: Crystal 150 as the current production flagship; IQM Star 24 as the first Star-topology system; IQM Constellation (combining Crystal and Star) as the planned QEC-era QPU architecture; IQM Halocene as the QEC research platform (150 qubits, commercial by end 2026). In 2025 IQM achieved the industry milestone of 99.95% CZ fidelity on a test chip. The roadmap identifies three high-value application areas: simulation (€28B market by 2035), optimization (€18B), and quantum machine learning (€26B), totaling over €72B. The company also disclosed in May 2026 delivery schedules for 150-qubit and 300-qubit machines to VTT. Manufacturing is supported by an Espoo production facility producing 20 QCs per year, with plans for significant expansion announced in November 2025 (€40M investment). [CE028, CE029, CE030, CE031, CE032, CE033]

5.5 Trust, Safety, Compliance, and Technology Risk

IQM's quality assurance rests on in-house manufacturing in a controlled cleanroom environment, module-level electronics testing, a dedicated system build area for full validation, and an automated testing suite. Cryogenic chip testing identifies functional QPU units before production, and the calibration team tunes each system on site post-installation. Delivery-to-installation typically under 6 months. IQM does not publicly disclose cybersecurity certifications, penetration test results, or third-party security audit reports for the Resonance cloud platform or the on-premises control systems—a gap relevant for government and defense customers. The Resonance platform is a js-only web application with limited visible API documentation. As a Finnish private company (as of May 2026, mid-SPAC process), IQM is not subject to a US national security review (CFIUS) for its European deliveries but its planned US listing and US deployments (ORNL, University of Maryland) may attract regulatory scrutiny. Export control exposure: superconducting quantum computers are considered dual-use technology in EU and US export classification frameworks; no public IQM-specific export compliance guidance is published. The SPAC merger registration statement (Form F-4, filed May 14, 2026, SEC Accession 0001193125-26-222654) is the first public financial disclosure. Key technology risk: dependency on NVIDIA NVQLink GPU-QPU interconnect for real-time QEC; if NVIDIA changes access terms or pricing, IQM's QEC roadmap could face delays. Additionally, the QLDPC code implementation timeline has no independently verifiable milestone publication. [CE037, CE038, CE039, CE040, CE041, CE042]

5.6 Exhibits

6.1 Customer Segmentation and Acquisition Map

IQM's customer base segments into four distinct cohorts. First, national quantum infrastructure programs—state-backed bodies that build and operate national quantum computing facilities as research infrastructure. This cohort includes VTT Technical Research Centre of Finland (IQM's founding reference customer and technology partner), CSC/FiQCI (Finnish Quantum Computing Infrastructure hosting Helmi and Aalto University's 20-qubit system), and the LUMI-Q consortium (nine-country EuroHPC consortium with an IQM Star 24 system at IT4Innovations, Czech Republic). Second, HPC supercomputing centers—institutions that integrate quantum hardware into their high-performance computing environments. This cohort includes LRZ (Leibniz Supercomputing Center, Germany; 20-qubit Radiance, 2024), ORNL (Oak Ridge National Laboratory, US; Radiance 20q selected for first on-prem QC), CESGA (Galicia Supercomputing Center, Spain; 54-qubit Radiance + 5-qubit Spark planned by June 2026), Cineca (Italy; Lagrange system), and Aalto University (Finland; 20-qubit HPC-connected). Third, academic and research universities—institutions acquiring IQM Spark for teaching, algorithm research, and quantum skills development. This cohort includes Chungbuk National University (South Korea; first Asia-Pacific IQM system), WUST (Poland; first Polish superconducting QC), Poznan University of Technology (Poland; unveiled 2026), and the University of Maryland (US; IQM quantum technology center opening 2026). Fourth, early enterprise adopters—private companies purchasing IQM hardware or using cloud access. Galaxy Systemy Informatyczne (Poland) was publicly announced as the first private enterprise to purchase an IQM quantum computer (April 2026). TOYO Corporation (Japan; distribution agreement + first enterprise purchase, April 2026) and Scientek Corporation (Taiwan; reseller agreement) extend IQM's reach into the Asia-Pacific enterprise market. DATEV (Germany) is collaborating on portfolio optimization use cases. [CU001, CU002, CU003, CU004, CU005, CU006]

6.2 Named Deployments and Customer Proof

VTT Technical Research Centre of Finland is IQM's longest-standing customer and technology co-development partner. IQM built the Helmi quantum computer (5 qubits, VTT's first system) and later VTT Q50 (50 qubits, the largest publicly accessible quantum computer in the Nordic countries, opened March 2025 through FiQCI). Under a publicly disclosed roadmap, VTT is scheduled to receive a 150-qubit IQM Crystal system in 2026 and a 300-qubit system in 2027, making VTT both the most advanced and largest single-customer program for IQM. LRZ (Leibniz Supercomputing Center, Munich, Germany) deployed IQM Radiance 20q in 2024 as part of the Munich Quantum Valley initiative, using the system with the Munich Quantum Software Stack in a loosely HPC-integrated configuration; the Cineca Director General is quoted on the IQM Radiance product page expressing confidence that quantum will translate into commercial opportunities. IT4Innovations (National Supercomputing Center, Czech Republic) operates the IQM Star 24 (VLQ system, 24-qubit Star topology), connected to the Karolina supercomputer, deployed through the LUMI-Q EuroHPC consortium and inaugurated in 2025. ORNL (Oak Ridge National Laboratory, US) selected IQM Radiance as its first on-premises quantum computer, with delivery initially scheduled for Q3 2025; this is the first IQM sale to a US Department of Energy lab. CESGA (Galicia Supercomputing Center, Spain) is deploying a 54-qubit Radiance and a 5-qubit Spark to be integrated with the Finisterrae IV AI-supercomputer by June 2026, in a project supported by Telefónica. Chungbuk National University (South Korea) installed IQM Spark in 2025 as the first IQM system deployed in the Asia-Pacific region. Galaxy Systemy Informatyczne (Poland) announced in April 2026 as the first private enterprise buyer of an IQM quantum computer. IQM hardware is also accessible via Amazon Braket (IQM Garnet and IQM Emerald) and Quantum Rings cloud platform. [CU011, CU012, CU013, CU014, CU015, CU016]

6.3 Adoption Trajectory and Growth Patterns

IQM's on-premises deployment count has grown from a single VTT installation (2021) to 10+ systems across multiple continents by 2026, and the company claims #1 status in on-premises deliveries globally for the past 12 months. The growth trajectory reflects three distinct phases: Phase 1 (2019–2022) was driven by national quantum programs in Finland, Germany, and IQM's founding partner ecosystem; Phase 2 (2023–2024) saw IQM win its first competitive HPC tenders (LRZ, ORNL selection, IT4Innovations) as quantum computers began entering supercomputing center procurements; Phase 3 (2025–2026) has expanded the geographic footprint to Asia-Pacific (South Korea, Japan, Taiwan) and introduced private enterprise adoption alongside continued national lab wins. The LUMI-Q consortium (nine countries) represents a single contract with multi-country deployment potential, as does the Scientek and TOYO distributor network in Asia. The CESGA deployment with Telefónica as a supporting partner suggests emerging telco vertical interest. On the cloud side, IQM's presence on Amazon Braket (Garnet 20q since 2023; Emerald 54q since July 2025) provides global developer reach. The Quantum Rings platform makes IQM hardware available for free to their ecosystem, serving as a developer acquisition channel. No public evidence of year-over-year revenue growth rates, order book size, or customer acquisition cost data is available; the first financial disclosure is expected through the SPAC process (Form F-4 filed May 2026). [CU021, CU022, CU023, CU024, CU025, CU026]

6.4 Retention, Renewal, and Customer Durability

IQM's retention profile is structurally strong in the national lab and supercomputing center cohort. VTT has a multi-year roadmap with IQM extending through at least 2027 (300-qubit system delivery), suggesting deep institutional lock-in driven by co-development history and shared IP. CSC's FiQCI connects VTT and Aalto systems under national infrastructure contracts that typically run 3–7 years. ORNL, CESGA, and IT4Innovations are government-funded institutions whose quantum computer budgets are tied to national or EU-level quantum programs; their contract durability depends on continued program funding, creating sovereign budget risk rather than competitive churn risk. Private enterprise customers (Galaxy Systemy, TOYO) are single-system buyers with no multi-year contract evidence publicly available, making early enterprise churn hard to assess. IQM has not published customer satisfaction metrics, NPS scores, or contract renewal rates. The first adverse signal: IQM's customer base is heavily weighted toward government-funded institutions (approximately 85–90% of known deployments), which are susceptible to budget cycles, government procurement delays, and geopolitical restrictions on dual-use technology acquisition. No IQM customer has publicly canceled or delayed a procurement once announced; the absence of churn evidence is noted but should be interpreted cautiously given the small observed sample size and recency of most deployments. The €50M bridge financing secured in March 2026 and the SPAC merger suggest the company has not yet achieved sustained commercial revenue to fund operations independently. [CU029, CU030, CU031, CU032, CU033, CU034]

6.5 Expansion Potential and Concentration Risk

IQM's customer expansion potential is driven by four dynamics: (1) upgrade cycles within existing accounts—VTT's progression from Helmi (5q) to Q50 (50q) to 150q and then 300q is a proof-of-concept for multi-generation spend; (2) geographic rollout—distributor agreements with TOYO (Japan) and Scientek (Taiwan) open the Asia-Pacific enterprise market, while CESGA and Cineca represent early southern-European wins; (3) cloud access as a land-and-expand funnel—Braket and Resonance users who eventually procure on-premises hardware; (4) new verticals through DATEV (financial services) and any pharmaceutical or logistics pilots derived from the quantum optimization/simulation roadmap. Concentration risk is elevated. VTT represents a disproportionate share of IQM's install base and public reputation—three planned systems (Q50 + 150q + 300q) across two or more contracts at a single institution. LRZ and Aalto University together with VTT form the Finnish-German national lab cluster that likely constitutes the majority of IQM's current HPC-grade contract revenue. The geographic concentration in EU/Nordic institutions means a portion of the revenue base is sensitive to EU quantum program budget cycles (including EuroHPC and national funding). The US market is nascent (ORNL selected, University of Maryland planned), with no delivered systems to the US as of May 2026. US government procurement regulations (FedRAMP, export control, CFIUS considerations given the SPAC listing) could slow US expansion. Adverse signal: IQM's SPAC F-4 filing (May 2026) will be the first opportunity to see disclosed revenue concentration data; until then, this gap remains a material diligence limitation. [CU036, CU037, CU038, CU039, CU040, CU041]

6.6 Exhibits

7.1 Regulatory and Export-Control Risk

IQM operates at the intersection of quantum physics and geopolitics. Quantum computers are classified as dual-use items under EU Regulation (EU) 2021/821 (the EU Dual-Use Regulation) and the Finnish Act on the Export Control of Dual-Use Items (Laki 500/2024). Both regimes require export licences or national-security approvals before shipment of systems above threshold qubit counts or performance benchmarks to restricted end-users. Multiple IQM customers sit in jurisdictions — Japan, Taiwan, Saudi Arabia, Poland — where export-control designations are evolving. IQM's F-4 registration statement filed with the SEC on 14 May 2026 explicitly flags export-control tightening as a material risk factor, noting that "export controls on quantum computing are quickly evolving and tightening" across EU member states and the United States. The Wassenaar Arrangement participants are actively reviewing quantum technology classifications for Category 3 electronics. Additionally, IQM's F-4 discloses that IQM must comply with US sanctions (OFAC) for any US-incorporated entity and its subsidiaries following the SPAC close. No export-licence violation or enforcement action has been publicly disclosed; however, regulatory uncertainty represents a structural headwind for IQM's international order book. Legal risk is also present through the F-4 registration process itself: the SEC must declare the registration statement effective before the SPAC can close, and any material comment letter from the SEC could delay the merger beyond IQM's cash runway window. The F-4 also reveals that IQM's technology is subject to government-funding body rights in EU-funded research, potentially constraining IP commercialisation. No litigation is disclosed as pending or threatened as of the filing date. [CR001, CR002, CR003, CR004, CR005, CR006]

7.2 Financial, Burn, and SPAC Execution Risk

IQM incurred net losses of €54.4 M in FY2025 and €54.1 M in FY2024, with an accumulated deficit of €232.2 M as of 31 December 2025. Revenue for FY2025 is reported at ≥$35 M (unaudited, EUR/USD 1.174) — approximately 51× the pre-money SPAC equity valuation of approximately $1.8 B. The company has raised $635 M+ in total funding (equity, debt, and public grants), including a $320 M Series B led by Ten Eleven Ventures in September 2025, and a €50 M debt financing facility drawn in March 2026. Post-SPAC cash is targeted at >$450 M: $175 M trust + $134 M PIPE + $24 M warrant exercise proceeds + $172 M existing cash (all as of year-end 2025). The key financial risk is SPAC execution: RAAQ public shareholders may redeem shares before close, eroding the trust account. Under the maximum contractual redemption scenario, the combined company would have materially less cash than the headline >$450 M target. The F-4 discloses that if remaining proceeds are ≤$100 M, all Sponsor Private Placement Warrants are forfeited — signalling a governance structure sensitive to redemption levels. IQM's F-4 also acknowledges no scalable business model has been established and that the company "expects to continue to incur operating and net losses annually until we generate significant revenue." A €40 M Finland fab-expansion capex commitment made in November 2025 adds further cash-consumption pressure. The burn risk kill criterion: if SPAC does not close and IQM cannot secure alternative bridge financing within 12 months, the company would need to reduce headcount and defer customer deliveries, undermining the commercial momentum critical to the valuation thesis. [CR008, CR009, CR010, CR011, CR012, CR013]

7.3 Technical, Supply-Chain, and Manufacturing Risk

IQM's technology roadmap targets 2027–2028 quantum error-correction demonstrators and fault-tolerant systems at 2030+. This requires scaling from current Radiance systems (up to 150 qubits) to architectures of millions of qubits — a challenge no competitor has achieved. The Halocene product line, launched in November 2025 for error correction, is still in pre-deployment development. IQM's F-4 risk factors explicitly identify "technological challenges in the development of our superconducting modality" and "limitations in manufacturing capacity" as business risks. Physical errors in superconducting qubits (decoherence, gate infidelity) must decrease by ~4–5 orders of magnitude to reach fault tolerance. The company's chip fabrication is currently concentrated at the Espoo, Finland cleanroom (7,250 sqm of corporate, R&D and fabrication space plus additional Espoo production space) and a planned expansion funded by >€40 M. Supply-chain concentration is acute. Dilution refrigerators — essential to cool qubits to near absolute zero — are primarily supplied by Bluefors, a Finnish company spun out of Aalto University. IQM's Espoo operations have geographic proximity to Bluefors but the global dilution-refrigerator market is an oligopoly (Bluefors, Oxford Instruments, Leiden Cryogenics) with lead times of 12–18 months. Control electronics depend on Zurich Instruments systems (IQM has a joint QEC demonstrator with ZI and NVIDIA NVQLink). Any single-supplier failure, US trade restriction on cryogenic components, or production yield decline would directly delay customer deliveries. As of run date, IQM has delivered 15 systems with 30+ built, and has 21 systems sold to 13 customers — a small but growing pipeline where each delivery delay has outsized revenue impact. [CR015, CR016, CR017, CR018, CR019, CR020]

7.4 Talent, Competition, and Customer-Concentration Risk

Talent scarcity is a category-level risk. IQM's own State of Quantum report (co-authored with analyst firm Omdia, June 2025) identifies quantum talent shortages as "the two biggest systemic risks to the industry's continued growth" alongside funding gaps outside the US. IQM employs 300+ people across 50+ nationalities including 120+ quantum PhDs. PhD-level quantum engineers take 5–7 years to train; the global annual output of quantum PhDs is estimated in the low thousands. IQM's January 2026 co-CEO transition (Jan Goetz appointed sole CEO after Mikael Silverstolpe departed) represents a key-person execution risk with a newly singular leadership structure entering a critical SPAC-close period. Customer concentration is structural. The F-4 states that "A significant portion of our revenue currently depends on contracts with the public sector." With only 13 disclosed customers, a single lost contract likely represents ≥7 % of total revenue. Most customers are government-funded institutions (universities, national labs, HPC centres) that follow procurement cycles of 12–36 months and are subject to budget constraints. Four of the top 10 supercomputing centres globally are IQM customers, which represents high-prestige concentration rather than diversification. Competition risk is intensifying. IBM continues to advance its superconducting roadmap (1,000+-qubit systems); IonQ (market cap ~$23.6 B as of run date) focuses on trapped-ion systems with cloud-first go-to-market; Quantinuum (Honeywell spin-out) is pursuing enterprise and pharmaceutical customers with high-fidelity trapped-ion hardware. IQM's on-premises model differentiates on sovereignty and ownership, but requires customers to bear capex — a higher friction purchase than cloud access. [CR021, CR022, CR023, CR024, CR025, CR026]

7.5 Mitigations, Monitoring Indicators, and Kill Criteria

IQM has implemented several risk mitigations. On export controls: the company maintains dual-use compliance programmes and has not disclosed any licence violations. The Finland headquarters provides EU regulatory clarity. On supply-chain: the Espoo fab expansion (>€40 M capex) and in-house chip manufacturing reduce third-party fabrication risk; the Bluefors proximity provides geographic supply-chain resilience. On talent: IQM's Finland base provides access to Aalto University and VTT Technical Research Centre talent pipelines. On customer concentration: the US quantum technology centre (Maryland, April 2026) and agreements in Japan (Toyo Corporation), Taiwan (Scientek) and Poland (Galaxy) signal geographic diversification of the customer base. On SPAC execution: a $134 M PIPE at $10/share is locked in (subject to customary conditions) providing a floor on post-close cash even under high-redemption scenarios. On competition: IQM's on-premises model creates switching costs and has been validated by ORNL (US DOE lab) adoption. Kill criteria that would break the investment thesis: (1) SPAC merger fails to close and no alternative capital event materialises within 12 months; (2) export-licence denials preventing delivery to ≥2 contracted customers; (3) a major competitor (IBM, Google) delivers a fault-tolerant demonstration system before 2028, compressing IQM's technology-roadmap runway; (4) FY2026 revenue falls below $35 M (no growth vs. FY2025), signalling commercial stall; (5) departure of CEO Jan Goetz within 24 months of sole-CEO appointment. [CR028, CR029, CR030, CR031, CR032]

7.6 Exhibits

8.1 Investment Thesis and Anti-Thesis

The core bull thesis for IQM rests on four pillars. First, IQM has built the largest disclosed revenue base ($35M+ FY2025) among pure-play quantum hardware companies, sold 21 systems to 13 institutional customers across Europe, Asia, and the United States — a customer acquisition rate that validates commercial readiness ahead of the IPO. Second, IQM's SPAC pre-money valuation of $1.8B implies only ~51x FY2025 revenue, an 86% discount to IonQ's ~365x, Rigetti's ~1,866x, and D-Wave's ~3,551x multiples. If IQM re-rates to even half of IonQ's multiple post-listing, it would imply an enterprise value exceeding $6B — a 3x-plus return from current implied pricing. Third, the $450M+ expected post-SPAC cash balance funds operations and R&D through the critical fault-tolerant proof-of-concept window without near-term dilutive financing. Fourth, IQM's scientific infrastructure — VTT, Aalto University, ORNL, LRZ partnerships, Nature publications — provides credible technology differentiation in superconducting architecture. The anti-thesis is equally compelling. The SPAC structure introduces binary execution risk: RAAC shareholders may elect full redemption, collapsing trust proceeds and forcing IQM to raise on worse terms. The F-4 explicitly acknowledges that IQM has historically incurred net operating losses and cannot predict when profitability will be achieved; accumulated deficit has reached €232.2M. FY2025 revenue of ≥$35M is described as "unaudited" — audited figures may revise downward or reveal revenue-recognition nuances (TCV vs. recognized revenue). Gross margin is not publicly disclosed. The broader sector risk is multiple compression: the 2025 quantum computing valuation surge was in part sentiment-driven, and a single missed commercial milestone industry-wide could revert multiples toward technology-sector medians. IQM is also competing against well-capitalised US incumbents and emerging Chinese national quantum programs. [CV001, CV002, CV003, CV008, CV010, CV012]

8.2 Recommendation and Valuation Context

The investment recommendation as of 26 May 2026 is "research-more." The primary gating factors are SPAC execution risk (binary outcome) and reliance on unaudited FY2025 financial metrics. Until SPAC close is confirmed and audited FY2025 financials are published, no entry price can be risk-adjusted with sufficient precision. If both gating conditions are cleared positively, the valuation case for a "buy" becomes compelling: IQM's ~51x implied revenue multiple is the lowest among all listed pure-play quantum companies, providing a structural re-rating catalyst simply from achieving listing. The financing context supports the bull thesis: IQM's September 2025 Series B ($320M at approximately $1.0B post-money) was followed six months later by a SPAC pre-money of $1.8B — an 80% step-up reflecting improved commercial momentum. Post-SPAC expected cash of >$450M (including $175M trust, $134M PIPE, and existing cash) is sufficient to fund operations through FY2028 at current burn rates (~€54M annual loss). The €50M debt facility drawn in March 2026 provides additional liquidity. The bookings backlog exceeds $100M, providing revenue visibility above the FY2025 base of ≥$35M. Confidence in this recommendation is medium, reflecting the quality of the underlying data. The risk rating is high: SPAC execution risk, unaudited financials, sector multiple volatility, and pre-profitability stage each independently justify a high-risk designation. [CV015, CV017, CV018, CV023, CV024, CV026]

8.3 Bull, Base, and Bear Valuation Scenarios

Three scenarios are constructed on IQM's FY2025 revenue of ≥$35M as the common base metric, using peer-derived revenue multiples as anchors. Each scenario is discrete and conditioned on explicit assumptions about SPAC execution, revenue recognition, and sector multiple trajectory. The bull case applies a 150x revenue multiple — approximately 41% of IonQ's current ~365x and far below Rigetti's ~1,866x — implying an enterprise value of approximately $5.25B. This scenario assumes SPAC closes successfully, audited revenue confirms ≥$35M, post-listing guidance implies 50%+ YoY growth, and sector multiples remain at or above current levels. Probability signal: low (≤20%), contingent on multiple conditions aligning simultaneously. The base case applies a 75x revenue multiple, implying an enterprise value of approximately $2.625B, broadly consistent with the SPAC post-money valuation of ~$2.25B after the $450M cash infusion. This scenario requires SPAC close, audited revenue in-line with unaudited estimates, and sector multiples holding near current levels. It represents the most likely outcome given the current trajectory of quantum computing sector valuations. Probability signal: medium (40–50%). The bear case applies a 25x revenue multiple — below even the sector floor implied by IQM's own SPAC pricing — implying an enterprise value of approximately $875M, a ~51% discount to the $1.8B pre-money. This scenario captures SPAC failure or a severe sector-wide de-rating (e.g., 70%+ multiple compression, a major commercial setback at a leading quantum company, or sustained risk-off macro environment). Probability signal: low-to-medium (25–35%), elevated relative to typical pre-IPO situations due to binary SPAC risk. [CV029, CV030, CV031, CV034, CV036, CV037]

8.4 Comparable Company Analysis

The comparable set comprises the three US-listed pure-play quantum computing companies with publicly disclosed quantum revenue: IonQ (IONQ), Rigetti Computing (RGTI), and D-Wave Quantum (QBTS). IBM and Google are excluded as their quantum programs are embedded within diversified businesses with no standalone quantum revenue. Quantinuum and PsiQuantum are excluded as they are private companies without publicly available financial metrics. The comp set is explicitly representative, not exhaustive, reflecting the current sparse public-market landscape for quantum hardware. The most striking finding from the comp analysis is the magnitude of IQM's multiple discount. IonQ, as the largest pure-play quantum company by market cap ($23.6B) and highest disclosed TTM revenue ($64.7M), trades at approximately 365x revenue — itself considered elevated versus mature tech multiples. Rigetti and D-Wave, with materially lower TTM revenues ($4.4M and $2.86M respectively), trade at 1,866x and 3,551x — ratios that largely reflect speculative positioning rather than near-term earnings power. IQM's implied 51x multiple, at more than $35M revenue, is the only comp that approaches a justifiable growth multiple for a hardware company in pre-profitability stage. This creates both the bull thesis (re-rating catalyst) and a structural risk (sector de-rating pulling all names lower). IQM's model — on-premises full-system deployment to institutional buyers — differs from IonQ's cloud-first model and D-Wave's annealer architecture. This makes direct multiple comparison imperfect but instructive: IQM's revenue reflects hardware sale and service revenue, which has different gross margin characteristics than cloud access fees. Direct gross margin comparison awaits post-SPAC audited disclosure. [CV004, CV005, CV006, CV007, CV008, CV018]

8.5 Exit Triggers and Final Diligence

The "research-more" recommendation will convert to "buy" only if: (1) SPAC close is confirmed (RAAC shareholder vote passes, redemptions stay below maximum threshold), (2) audited FY2025 revenue is ≥$35M and revenue recognition methodology is clarified (contract vs. recognized), (3) gross margin disclosure confirms acceptable unit economics (target: ≥30% gross margin for a hardware company at this stage), and (4) post-listing management guidance demonstrates operating leverage — either narrowing losses at constant revenue or accelerating revenue growth without proportional cost increase. The "sell" triggers are: SPAC deal collapse or announcement of deal restructuring at a lower valuation; audited revenue materially below $35M (>20% miss); sector-wide multiple compression exceeding 60% (IonQ market cap falling below $9B); or emergence of a material undisclosed liability from the F-4 review process. The current 80% step-up from Series B to SPAC (Sep 2025 to Feb 2026) must be validated by commercial traction, not just sentiment. Final diligence priorities include: (1) reviewing the full F-4 once public for audited financials and revenue recognition policy, (2) obtaining gross margin and COGS data, (3) understanding lock-up structure and earn-out provisions for IQM founders and early investors, (4) quantifying RAAC shareholder redemption exposure, and (5) assessing whether IQM's government-sector revenue concentration creates contract renewal risk in the post-listing reporting environment. No independent analyst coverage existed as of May 2026; sell-side initiation post-listing will be a key valuation information catalyst. [CV009, CV011, CV019, CV036, CV037, CV040]